Kenvue said Monday that its board was taking steps to realize shareholder value and allow the company to “reach its full ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the ...

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...

Kenvue, formerly part of Johnson & Johnson, announces CEO Thibaut Mongon's departure as it undergoes a strategic review.

American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...

Alongside the leadership change, Kenvue revealed that its Board had previously initiated a comprehensive review of strategic alternatives and established a Strategic Review Committee. The review will ...

The consumer health company also disclosed its CEO’s departure, following its CFO replacement earlier this year, and appointed an interim chief executive. Preliminary second-quarter 2025 results show ...

When fully complete, the new campus will house some 3,000 employees. A new beginning “Today, I am very excited to mark a major milestone for our future,” said Kenvue CEO Thibaut Mongon. “One ...

Kenvue raked in $14.95 billion in sales for 2022 and a net income of $1.46 billion on a pro forma basis, according to the preliminary prospectus. Kenvue trades under the stock ticker "KVUE." Also ...

Kenvue CEO Thibaut Mongon has stepped down as the company’s chief executive and departed its board of directors. The CEO of Tylenol maker Kenvue ( KVUE) has left the company as part of an internal ...